Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Int J Drug Policy. 2016 Mar 2;36:141–147. doi: 10.1016/j.drugpo.2016.02.022

Table 2. Point Estimates and Univariate Tests of Method of Administration Among MML Features (MML Status / Duration of MML / Dispensary Density).

Ever Used Method Preferred Method
Smoke Vape* Edible* Smoke* Vape Edible
MML Status
 No 99.7% 53.8% 68.0% 84.3% 19.1% 8.1%
 Yes 99.5% 68.6% 77.6% 78.9% 21.7% 9.25%

Duration of MML
 No MML 99.7% 53.8% 68.0% 84.3% 19.1% 8.1%
 0-5 years 99.5% 66.7% 71.5% 78.8% 23.9% 9.5%
 6-10 years 100% 62.9% 82.3% 84.6% 17.3% 5.6%
 > 10 years 99.4% 72.9% 86.1% 77.7% 19.5% 9.8%

Dispensary (per 100k people)
 No MML 99.7% 53.8% 68.0% 84.3% 19.1% 8.1%
 0 99.5% 66.4% 73.2% 80.9% 21.9% 7.9%
 < 1 100% 68.1% 77.3% 75.7% 23.9% 13.8%
 ≥ 1 99.4% 72.3% 84.9% 76.5% 21.0% 10.0%

Chi squared tests used to calculate p-values

*

All three comparisons (MML Status, Duration MML, and Dispensary) for that method were significant (p<0.01)

Among those who had ever used that method of administration